Focal adhesion kinase: from biological functions to therapeutic strategies

X Tan, Y Yan, B Song, S Zhu, Q Mei, K Wu - Experimental Hematology & …, 2023 - Springer
Focal adhesion kinase (FAK), a nonreceptor cytoplasmic tyrosine kinase, is a vital
participant in primary cellular functions, such as proliferation, survival, migration, and …

New insights into FAK structure and function in focal adhesions

J Le Coq, I Acebrón, B Rodrigo Martin… - Journal of Cell …, 2022 - journals.biologists.com
Focal adhesion kinase (FAK; also known as PTK2) was discovered three decades ago and
is now recognised as a key player in the regulation of cell–matrix adhesion and …

CD155 and its receptors in cancer immune escape and immunotherapy

R Zhou, S Chen, Q Wu, L Liu, Y Wang, Y Mo, Z Zeng… - Cancer letters, 2023 - Elsevier
In recent years, there have been multiple breakthroughs in cancer immunotherapy, with
immune checkpoint inhibitors becoming the most promising treatment strategy. However …

[HTML][HTML] Cancer cell-intrinsic PD-1: Its role in Malignant progression and immunotherapy

M Chen, L Bie, J Ying - Biomedicine & Pharmacotherapy, 2023 - Elsevier
Programmed cell death protein-1 (PD-1), also called CD279, is coded by the PDCD1 gene
and is constitutively expressed on the surface of immune cells. As a receptor and immune …

Long non-coding RNA NRSN2-AS1 promotes ovarian cancer progression through targeting PTK2/β-catenin pathway

YB Wu, SY Li, JY Liu, JJ Xue, JF Xu, T Chen… - Cell Death & …, 2023 - nature.com
As a common malignant tumor among women, ovarian cancer poses a serious threat to their
health. This study demonstrates that long non-coding RNA NRSN2-AS1 is over-expressed …

Focal adhesion kinase signaling–tumor vulnerabilities and clinical opportunities

DD Schlaepfer, M Ojalill… - Journal of Cell …, 2024 - journals.biologists.com
Focal adhesion kinase (FAK; encoded by PTK2) was discovered over 30 years ago as a
cytoplasmic protein tyrosine kinase that is localized to cell adhesion sites, where it is …

TIGIT: An emerging immune checkpoint target for immunotherapy in autoimmune disease and cancer

J Zhao, L Li, H Yin, X Feng, Q Lu - International immunopharmacology, 2023 - Elsevier
Immune checkpoints (ICs), also referred to as co-inhibitory receptors (IRs), are essential for
regulating immune cell function to maintain tolerance and prevent autoimmunity. IRs, such …

Focal adhesion kinase priming in pancreatic cancer, altering biomechanics to improve chemotherapy

KJ Murphy, J Zhu, M Trpceski, BA Pereira… - Biochemical Society …, 2022 - portlandpress.com
The dense desmoplastic and fibrotic stroma is a characteristic feature of pancreatic ductal
adenocarcinoma (PDAC), regulating disease progression, metastasis and response to …

The dual blockade of the TIGIT and PD-1/PD-L1 pathway as a new hope for ovarian cancer patients

A Pawłowska, W Skiba, D Suszczyk, W Kuryło… - Cancers, 2022 - mdpi.com
Simple Summary Ovarian cancer (OC) is the most lethal gynecological malignancy with a
five-year survival rate of 47%, followed by cervical cancer (66%), and uterine cancer (81%) …

CD155 and its receptors as targets for cancer therapy

R Paolini, R Molfetta - International Journal of Molecular Sciences, 2023 - mdpi.com
CD155, also known as the poliovirus receptor, is an adhesion molecule often overexpressed
in tumors of different origins where it promotes cell migration and proliferation. In addition to …